Novel mutations in the CYP11B2 gene causing aldosterone synthase deficiency

Li,Niu; Li,Juan; Ding,Yu; Yu,Tingting; Shen,Yongnian; Fu,Qihua; Shen,Yiping; Huang,Xiaodong; Wang,Jian

doi:10.3892/mmr.2016.4906

Novel mutations in the CYP11B2 gene causing aldosterone synthase deficiency

Authors:
- Niu Li
- Juan Li
- Yu Ding
- Tingting Yu
- Yongnian Shen
- Qihua Fu
- Yiping Shen
- Xiaodong Huang
- Jian Wang
View Affiliations

Affiliations: Institute of Pediatric Translational Medicine, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, P.R. China, Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, P.R. China
Published online on: February 18, 2016 https://doi.org/10.3892/mmr.2016.4906
Pages: 3127-3132

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aldosterone synthase deficiency (ASD) is a rare, autosomal recessive inherited disease. Mutations in the CYP11B2 gene are responsible for the occurrence of ASD, and the clinical manifestations of ASD vary with age. Affected infants may develop symptoms of mineralocorticoid deficiency, including clinical presentation with frequent vomiting, a variable degree of hyponatremia, hyperkalemia, and metabolic acidosis combined with poor growth, which are easily confused with several other endocrine genopathies, including pseudohypoaldosteronism type 1 and congenital adrenal hyperplasia. In the present study, whole exome sequencing (WES) was used to screen for causal variants in the genome of a Chinese pediatric patient with confusing endocrine disorder symptoms. Clinical symptoms of frequent vomiting, hyponatremia and hyperkalemia were selected as the filtering indices to analyze the WES data. Clinically relevant variants were subsequently verified using Sanger sequencing. Minigene construct analysis was used to assess the consequence of a splicing variant in the CYP11B2 gene. The compound heterozygous mutations, c.1009C>T and c.240‑1G>A, in the CYP11B2 gene were identified and confirmed, and represented novel variants. Sequence analysis results revealed that the c.1009C>T mutation at codon 337 of exon 6 was a nonsense mutation, which led to early termination of the protein translation process. In addition, further investigation of the splicing pattern in a minigene construct showed that the c.240‑1G>A mutation led to the preservation of intron 1, with the 3'‑splice site disappearing during transcriptional processing of the mRNA. Using molecular genetic assessments, the patient was finally diagnosed with ASD. Therefore, the present study identified two novel CYP11B2 gene mutations in a Chinese patient with ASD, indicating exome sequencing as an effective diagnostic tool for rare endocrine-metabolic diseases.

View Figures

View References

1	Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL and White PC: The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol. 5:1513–1522. 1991. View Article : Google Scholar : PubMed/NCBI
2	White PC: Aldosterone synthase deficiency and related disorders. Mol Cell Endocrinol. 217:81–87. 2004. View Article : Google Scholar : PubMed/NCBI
3	Peter M: Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency. Semin Reprod Med. 20:249–254. 2002. View Article : Google Scholar : PubMed/NCBI
4	Kondo E, Nakamura A, Homma K, Hasegawa T, Yamaguchi T, Narugami M, Hattori T, Aoyagi H, Ishizu K and Tajima T: Two novel mutations of the CYP11B2 gene in a Japanese patient with aldosterone deficiency type 1. Endocr J. 60:51–55. 2013. View Article : Google Scholar
5	Bin-Abbas B, Al-Humaida D, Al-Sagheir A, Qasem E, Almohanna M and Alzahrani AS: Divergent gender identity in three siblings with 46XX karyotype and severely virilizing congenital adrenal hyperplasia caused by a novel CYP11B1 mutation. Endocr Pract. 20:e191–e197. 2014. View Article : Google Scholar : PubMed/NCBI
6	Wasniewska M and De Luca F, Valenzise M, Lombardo F and De Luca F: Aldosterone synthase deficiency type I with no documented homozygous mutations in the CYP11B2 gene. Eur J Endocrinol. 144:59–62. 2001. View Article : Google Scholar : PubMed/NCBI
7	Wang J, Yu T, Yin L, Li J, Yu L, Shen Y, Yu Y, Shen Y and Fu Q: Novel mutations in the SCNN1A gene causing Pseudohypoaldosteronism type 1. PLoS One. 8:e656762013. View Article : Google Scholar : PubMed/NCBI
8	Portrat S, Mulatero P, Curnow KM, Chaussain JL, Morel Y and Pascoe L: Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2 (aldosterone synthase) cause steroid 11 beta-hydroxylase deficiency and congenital adrenal hyperplasia. J Clin Endocrinol Metab. 86:3197–3201. 2001.PubMed/NCBI
9	Rodrigues SM, LeDoux JE and Sapolsky RM: The influence of stress hormones on fear circuitry. Annu Rev Neurosci. 32:289–313. 2009. View Article : Google Scholar : PubMed/NCBI
10	Wang J, Zhang W, Jiang H, Wu BL, Primary Ovarian and Insufficiency Collaboration: Mutations in HFM1 in recessive primary ovarian insufficiency. N Engl J Med. 370:972–974. 2014. View Article : Google Scholar : PubMed/NCBI
11	Brown NJ: Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol. 9:459–469. 2013. View Article : Google Scholar : PubMed/NCBI
12	Peter M, Dubuis JM and Sippell WG: Disorders of the aldo-sterone synthase and steroid 11beta-hydroxylase deficiencies. Horm Res. 51:211–222. 1999. View Article : Google Scholar
13	Nguyen HH, Hannemann F, Hartmann MF, Malunowicz EM, Wudy SA and Bernhardt R: Five novel mutations in CYP11B2 gene detected in patients with aldosterone synthase deficiency type I: Functional characterization and structural analyses. Mol Genet Metab. 100:357–364. 2010. View Article : Google Scholar : PubMed/NCBI
14	Ezquieta B and Luzuriaga C: Neonatal salt-wasting and 11 beta-hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosterone synthase)-CYP11B1 (11 beta-hydroxylase). Clin Genet. 66:229–235. 2004. View Article : Google Scholar : PubMed/NCBI
15	Kondo E, Nakamura A, Homma K, Hasegawa T, Yamaguchi T, Narugami M, Hattori T, Aoyagi H, Ishizu K and Tajima T: Two novel mutations of the CYP11B2 gene in a Japanese patient with aldosterone deficiency type 1. Endocr J. 60:51–55. 2013. View Article : Google Scholar
16	Stapenhorst L: 9alpha-Fluorohydrocortisone therapy in aldosterone synthase deficiency. Pediatr Nephrol. 20:8392005. View Article : Google Scholar : PubMed/NCBI
17	Hui E, Yeung MC, Cheung PT, Kwan E, Low L, Tan KC, Lam KS and Chan AO: The clinical significance of aldosterone synthase deficiency: Report of a novel mutation in the CYP11B2 gene. BMC Endocr Disord. 14:292014. View Article : Google Scholar : PubMed/NCBI
18	Schiffer L, Anderko S, Hannemann F, Eiden-Plach A and Bernhardt R: The CYP11B subfamily. J Steroid Biochem Mol Biol. 151:38–51. 2015. View Article : Google Scholar
19	Nishimoto K, Nakagawa K, Li D, Kosaka T, Oya M, Mikami S, Shibata H, Itoh H, Mitani F, Yamazaki T, et al: Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab. 95:2296–2305. 2010. View Article : Google Scholar : PubMed/NCBI
20	Wang J and Shen Y: When a “disease-causing mutation” is not a pathogenic variant. Clin Chem. 5:711–713. 2014. View Article : Google Scholar
21	Mamanova L, Coffey AJ, Scott CE, Kozarewa I, Turner EH, Kumar A, Howard E, Shendure J and Turner DJ: Target-enrichment strategies for next-generation sequencing. Nat Methods. 7:111–118. 2010. View Article : Google Scholar : PubMed/NCBI